近2年我们尝试对11例肝硬变伴原发性肝癌顽固血性腹水患者进行自身腹水回输治疗,取得一定效果。本组11例全部男性,年龄35～65岁,均有肝炎病史,HBsAg阳性,实验室检查(肝功、AFP、AKP、r-GT),B超、CT检查结果诊断为肝硬变伴原发性肝癌。腹水出现时间3个月至2年,平均9个月。血性腹水符合Natelson提出的诊断标准:1.外观血性。2.红细胞计数大于5万。腹水常规除外感染和癌细胞阳性。全部病人均限盐限水,应用利尿剂情况下,每日尿量250～450ml。 In the past two years, we tried to treat 11 cases of liver cirrhosis with hepatocellular carcinoma patients with hemorrhagic hemorrhagic ascites transfusion therapy, and achieved some results. The group of 11 cases of all men, aged 35 to 65 years old, have a history of hepatitis, HBsAg positive, laboratory tests (liver function, AFP, AKP, r-GT), B ultrasound, CT diagnosis of liver cirrhosis with progenitor Hepatic cancer. Ascites occurs for 3 months to 2 years, an average of 9 months. Bloody ascites meets the diagnostic criteria proposed by Natelson: 1. Appearance bloody. 2. Red blood cell count greater than 50,000. Ascites routine infection and cancer-positive. All patients were limited salt water, the use of diuretics, daily urine output 250 ~ 450ml.